Literature DB >> 11196545

Carpal tunnel sonography by the rheumatologist versus nerve conduction study by the neurologist.

W A Swen1, J W Jacobs, F E Bussemaker, J W de Waard, J W Bijlsma.   

Abstract

OBJECTIVE: To determine the value of sonography (SG) performed by the rheumatologist to diagnose carpal tunnel syndrome (CTS).
METHODS: Sixty-three patients with clinical signs of CTS according to the neurologist, based on patient history and clinical examination, were studied. In the 6 weeks prior to surgery, SG was performed by a rheumatologist and nerve conduction study (NCS) was assessed. Improvement of initial complaints of 90% or more 3 months after surgery was considered to be the post-hoc gold standard for the diagnosis of CTS.
RESULTS: After surgery, 47 patients (75%) experienced > or = 90% relief of complaints. Mean cross sectional area of the median nerve for patients with CTS was 11.3 mm2 compared to 6.1 mm2 in the control group. The sensitivity to detect CTS was 0.70 for SG and 0.98 for NCS, and specificity was 0.63 for SG and 0.19 for NCS. Positive predictive value was 0.85 for SG and 0.78 for NCS; negative predictive value was 0.42 for SG and 0.75 for NCS. Accuracy was 0.68 for SG and 0.78 for NCS.
CONCLUSION: CTS can be identified by SG less sensitively but more specifically than by NCS.

Entities:  

Mesh:

Year:  2001        PMID: 11196545

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Ultrasound-guided insulin injection for carpal tunnel syndrome in type 2 diabetes mellitus patients.

Authors:  Shereen Refaat Kamel; Hanaa A Sadek; Ahmed Hamed; Omima A Sayed; Mona H Mahmud; Fatma A Mohamed; Ghada M El Sagher; Lamia H Aly
Journal:  Clin Rheumatol       Date:  2019-06-17       Impact factor: 2.980

Review 2.  Grey-scale sonography and sonoelastography for diagnosing carpal tunnel syndrome.

Authors:  Hideaki Miyamoto; Yutaka Morizaki; Takahiro Kashiyama; Sakae Tanaka
Journal:  World J Radiol       Date:  2016-03-28

3.  Ultrasonographic measurement of the median nerve in patients with rheumatoid arthritis without symptoms or signs of carpal tunnel syndrome.

Authors:  Hilde Berner Hammer; Espen A Haavardsholm; Tore Kristian Kvien
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

4.  Screening for carpal tunnel syndrome using sonography.

Authors:  Shawn C Roll; Kevin D Evans; Xiaobai Li; Miriam Freimer; Carolyn M Sommerich
Journal:  J Ultrasound Med       Date:  2011-12       Impact factor: 2.153

Review 5.  Psoriatic arthritis assessment tools in clinical trials.

Authors:  P J Mease; C E Antoni; D D Gladman; W J Taylor
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 6.  Advances in the pathogenesis and treatment of patients with stiff person syndrome.

Authors:  Marinos C Dalakas
Journal:  Curr Neurol Neurosci Rep       Date:  2008-01       Impact factor: 5.081

7.  Sensitivity and specificity of median nerve ultrasonography in diagnosis of carpal tunnel syndrome.

Authors:  Mohammad Yazdchi; Mohammad Kazem Tarzemani; Haleh Mikaeili; Hormoz Ayromlu; Hooman Ebadi
Journal:  Int J Gen Med       Date:  2012-01-26

8.  Comparison of high-resolution sonography and electrophysiology in the diagnosis of carpal tunnel syndrome.

Authors:  Meena Angamuthu Kanikannan; Demudu Babu Boddu; Sailaja Sarva; Padmaja Durga; Rupam Borgohain
Journal:  Ann Indian Acad Neurol       Date:  2015 Apr-Jun       Impact factor: 1.383

9.  Carpal tunnel syndrome: Analyzing efficacy and utility of clinical tests and various diagnostic modalities.

Authors:  Gaurav M Kasundra; Isha Sood; Amita N Bhargava; Bharat Bhushan; Kirti Rana; Hemant Jangid; Khichar Shubhkaran; Guruprasad S Pujar
Journal:  J Neurosci Rural Pract       Date:  2015 Oct-Dec

10.  Exploratory use of ultrasound to determine whether demyelination following carpal tunnel syndrome co-exists with axonal degeneration.

Authors:  Xue Deng; Lai-Heung Phoebe Chau; Suk-Yee Chiu; Kwok-Pui Leung; Sheung-Wai Li; Wing-Yuk Ip
Journal:  Neural Regen Res       Date:  2018-02       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.